New: Think Tank Rankings 2025
Field of Research: Biology & Biochemistry » Category: Pharmacology & Pharmacy
Agricultural Sciences
Arts & Humanities
Biology & Biochemistry
Chemistry
Clinical Medicine
Computer Science
Economics & Business
Engineering
Environment and Ecology
Geosciences
History & Archaeology
Literature & Language
Materials Science
Mathematics
Multidisciplinary
Philosophy & Religion
Physics
Plant & Animal Science
Psychiatry and Psychology
Social Sciences
Visual & Performing Arts
Agriculture, Dairy & Animal Science
Agriculture, Multidisciplinary
Agronomy
Anatomy & Morphology
Andrology
Biochemical Research Methods
Biochemistry & Molecular Biology
Biology
Biophysics
Biotechnology & Applied Microbiology
Cell & Tissue Engineering
Cell Biology
Chemistry, Medicinal
Developmental Biology
Entomology
Environmental Sciences
Evolutionary Biology
Fisheries
Food Science & Technology
Genetics & Heredity
Marine & Freshwater Biology
Mathematical & Computational Biology
Microbiology
Mycology
Neurosciences
Parasitology
Pathology
Pharmacology & Pharmacy
Physiology
Psychology, Biological
Reproductive Biology
Toxicology
Virology
Zoology

Pharmacology & Pharmacy

Latest Papers
(Limited to the last 10 days and a maximum of 250 papers)
12
Jan
2026
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Proposal of metagenomic-origin LRA-5 as a precursor of active β-lactamases through Tyr69Gln and Val166Glu amino acid substitutions: a functional and s Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Ceftobiprole alone versus ampicillin-ceftriaxone against borderline-penicillin-resistant, ampicillin-susceptible, and vancomycin-resistant Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Repurposing epetraborole to combat Neisseria gonorrhoeae and Chlamydia trachomatis Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Impact of Pseudomonas aeruginosa biofilm exopolysaccharide composition on bacteriophage and bacteriophage-anti Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase- Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Population pharmacokinetics and dose optimization of piperacillin-tazobactam in premature and term neonates with severe infections Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
The molecular basis of intrinsic resistance to azoles in Rhizopus arrhizus Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
A patient-centric paradigm and tool for clinical research: the DOOR is open Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Beyond mecA : a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinic Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Safety, tolerability, and pharmacokinetics of a 2 g subcutaneous dose of ceftriaxone as an alternative to intravenous delivery Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pha Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and en Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
Vitamin C enhances corneal fungal infection treatment in mice via chemotaxis and anti-inflammation Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
The effect of antacid and mineral supplements on bictegravir pharmacokinetics: results from a Phase 1, open-label, drug–drug interaction study Gold Open Access
Antimicrobial Agents and Chemotherapy
12
Jan
2026
l -Arginine combined with 5-fluorouracil inhibits EMT by regulating iNOS expression in hepatocellular carcinoma
Xenobiotica
12
Jan
2026
α-Hederin inhibits osteosarcoma progression by triggering ferroptosis and disrupting mitochondrial function via PI3K/AKT signalling
Xenobiotica
12
Jan
2026
Fluorescent Dyes as Functional Probes for Studying Drug-Transporting Solute Carriers
Xenobiotica
12
Jan
2026
The Mitochondrial Protective Mechanisms Mediated by SGLT2i: From Molecular Basis to Clinical Implications
Xenobiotica
12
Jan
2026
Methyl mercury pharmacokinetics in man: a five-compartment hybrid model
Xenobiotica
12
Jan
2026
Efficacy of IncobotulinumtoxinA (BoNT-A) Injection in Task-Specific Tremors
Toxicon
12
Jan
2026
Efficacy of Botulinum Neurotoxin Type A in the Treatment of Concomitant Tics and Cervical Dystonia With Regression of the Sensory Phenomenon (Premonit
Toxicon
12
Jan
2026
A HiPSC Based Activity Assay for the Detection of Botulinum Neurotoxin Serotypes A and E in Non-clinical Samples
Toxicon
12
Jan
2026
Botulinum Neurotoxin Type A for the Treatment of Upper Limb Dystonia Following Recurrent TBI: A Case Report
Toxicon
12
Jan
2026
Electrical or Magnetic Nerve Stimulation Enhance BoNT-A-Mediated Muscle Paralysis
Toxicon
12
Jan
2026
Botulinum Neurotoxins: A Distinct Subclass of SNARE-Cleaving Endopeptidases
Toxicon
12
Jan
2026
Management of Therapeutic Failure due to Clinical Resistance to Botulinum Neurotoxin Type A in Chronic Pediatric Patients: Evidence of Response Recove
Toxicon
12
Jan
2026
A Longitudinal Study on the Onset and Sustained Benefits of OnabotulinumtoxinA: Insights From the PREEMPT Trials
Toxicon
12
Jan
2026
IncobotulinumtoxinA for the treatment of lower limb spasticity in children and adolescents with cerebral palsy: Evaluation of Lower Limb Incobotulinum
Toxicon
12
Jan
2026
Persistence With Botulinum Neurotoxin Type A and Factors Associated With Discontinuation: A Retrospective Cohort Study
Toxicon
12
Jan
2026
Similar and Limited In Vivo Diffusion for RelaBoNT-A and OnaBoNT-A
Toxicon
12
Jan
2026
CPT Coding for Head, Neck, and Shoulders: Bigger Headache Than the Procedure
Toxicon
12
Jan
2026
Development of a European Equine Tetravalent Botulism Antitoxin and Novel Purified F(ab’)2 Botulinum Type A, B, E and F Antitoxin Reference Materials
Toxicon
12
Jan
2026
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Masseter Muscle Prominence in a Chinese Population: 6-Month Results From a Phase 3, Ran
Toxicon
12
Jan
2026
Neuromorphology of the Receptor System in Phantom Pain Syndrome
Toxicon
12
Jan
2026
Post-COVID Cervical Dystonia: A Case Report
Toxicon
12
Jan
2026
Multimodal Imaging Biomarkers for the Evaluation and Management of Spasticity: Magnetic Resonance Imaging, B-mode Ultrasound, and Shear Wave Elastogra
Toxicon
12
Jan
2026
Characteristics of IncobotulinumtoxinA Treatment for Cervical Dystonia in a Real-World Setting: Dosing and Muscles Injected
Toxicon
12
Jan
2026
Utilizing a Novel Botulinum Toxin to Investigate Intracellular Trafficking
Toxicon
12
Jan
2026
Real-World Spasticity Management and Goal Attainment With IncobotulinumtoxinA: Case Reports From the UK
Toxicon
12
Jan
2026
Botulinum Toxin in Motor Recovery: Innovation in Neurorehabilitation
Toxicon
12
Jan
2026
Electromyography-Guided Unilateral Botulinum Toxin Injection for Retrograde Cricopharyngeus Dysfunction (R-CPD): Dose Effects, Sex Differences, and Cl
Toxicon
12
Jan
2026
Long-Term Utilization of OnabotulinumtoxinA for the Treatment of Overactive Bladder
Toxicon
12
Jan
2026
The Role of Electromyography in the Botulinum Neurotoxin Therapy of Cervical Dystonia
Toxicon
12
Jan
2026
Use of Botulinum Neurotoxin Type A for Pain Management in Osteoarthritis: A Clinical Case Report
Toxicon
12
Jan
2026
Cholinergic Premotor Inputs in the Spinal Cord Augment the Focal Experimental Spasticity
Toxicon
12
Jan
2026
BoSapient®, a Cell-Based BoNT-A Potency Assay Optimized for Manual and Semi-Automated Procedures
Toxicon
12
Jan
2026
Refractory Meige Syndrome Successfully Treated With Bilateral Globus Pallidus Internus Deep Brain Stimulation
Toxicon
12
Jan
2026
Effects of Apomorphine, Spinal rTMS, and BoNT on Camptocormia: An Exploratory Wearable Sensor-Based Analysis in a Patient With MSA
Toxicon
12
Jan
2026
Pharmacological Differences Between Botulinum Toxin Type A 900 kDa Complex and 150 kDa Neurotoxin Protein
Toxicon
12
Jan
2026
Botulinum Toxin Type A for Vincristine-Induced Neuropathic Pain: A Case Report
Toxicon
12
Jan
2026
Blepharospasm Presenting as Facial Pain and “Sinus” Headache: A Case Series
Toxicon
12
Jan
2026
Combined Botulinum Toxin and Focused Ultrasound Therapy for Severe Jaw Tremor: A Case Report
Toxicon
12
Jan
2026
Twists and Turns of the Neck in Cervical Dystonia and Their Impact on the Cervical Spine
Toxicon
12
Jan
2026
Three Cases of Hemimasticatory Spasm: Successful Use of Botulinum Neurotoxin
Toxicon
12
Jan
2026
Service Evaluation of Diagnostic Nerve Block Clinics Within the Oxford Spasticity Service
Toxicon
12
Jan
2026
Bilateral Obturator and Pudendal Nerve Blocks With OnabotulinumtoxinA to Ameliorate Symptoms of IC/BPS With a Follow-Up of > 10 years
Toxicon
12
Jan
2026
Studying Botulinum Toxin Diffusion in Spastic Patients Using High-Density Surface EMG: A Clinical and Electrophysiological Perspective
Toxicon
12
Jan
2026
Review of Phase 1 Pharmacodynamic Models to Characterize Botulinum Neurotoxins: Ability to Assess Onset, Duration, Diffusion, and Pain Threshold in Ea
Toxicon
12
Jan
2026
Evaluation of Clinically Meaningful Pain Reduction in Adult Patients With Spasticity Following Treatment With OnabotulinumtoxinA
Toxicon
12
Jan
2026
Botulinum NeuroToxin Type A Injections for the Prevention of Aspiration Complications in Patients With Neurogenic Dysphagia and Posterior Sialorrhea o
Toxicon
12
Jan
2026
Efficacy and Safety of Botulinum Toxin Injections for Refractory Dejerine-Roussy Thalamic Pain Syndrome: A Case Series
Toxicon
12
Jan
2026
Presynaptic Terminal Proteins and Nicotinic Receptors Are Depleted From Mouse Parasympathetic Ganglionic Junctions Paralyzed With Botulinum Neurotoxin
Toxicon
12
Jan
2026
A Simple Test for Assessing the Contribution of Toe Flexion to Hindfoot Position: The Lewicke Block Test
Toxicon
12
Jan
2026
Real-World Use of Botulinum Neurotoxin Type A for Hyperkinetic Movement Disorders: Insights From a French Nationwide Registry (2015-2023)
Toxicon
12
Jan
2026
Efficacy of IncobotulinumtoxinA in the Management of Spasticity and Dystonia in a Pediatric Patient with NUBPL-Related Mitochondrial Disease: A Case R
Toxicon
12
Jan
2026
Real Life Experiences and Practical Impact of Using Bespoke Electronic Patient Record Systems in the Neurology Botulinum Neurotoxin Clinic at Leeds
Toxicon
12
Jan
2026
In Vitro and In Vivo Comparison of the Complex-Protein-free Botulinum Neurotoxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA, and Rel
Toxicon
12
Jan
2026
Central Trans-Synaptic Migration of Botulinum Neurotoxin Type A in the Sensory and Motor Nervous Systems
Toxicon
12
Jan
2026
Understanding the Socio-Economic Impact of Optimized BoNT Adoption
Toxicon
12
Jan
2026
Sequential Administration of TrenibotulinumtoxinE and OnabotulinumtoxinA for Glabellar Lines: A Phase 1 Evaluation
Toxicon
12
Jan
2026
Quality Improvement Project Towards a Sustainable Ultrasound Guided Botulinum Toxin Service
Toxicon
12
Jan
2026
Patterns of Botulinum Neurotoxin Treatment in Parkinsonian Syndromes: A Nationwide French Study (2015-2023)
Toxicon
12
Jan
2026
Using SNAP25 Cleavage to Compare Diffusion Across Different BoNT-A Commercial Preparations
Toxicon
12
Jan
2026
Synaptic Vesicle Protein 2-Targeted Delivery of Liposomal Doxorubicin via Botulinum Neurotoxin Type A Binding Domain Achieves Potent Neuroblastoma The
Toxicon
12
Jan
2026
Effect of First-Time Botulinum Toxin Type A Injection in Gastrocnemius Muscle in Spastic Children With Cerebral Palsy: An Elastographic Study
Toxicon
12
Jan
2026
Redefining the Range: Clinical Insights Into the Use of Higher-Dose DaxibotulinumtoxinA
Toxicon
12
Jan
2026
Use of Botulinum Toxin and Phenol for the Treatment of Muscle Tone Disorders in Children Treated at a Rehabilitation Center
Toxicon
12
Jan
2026
Botulinum Neurotoxin Type-A in the Treatment of Patients With Paratonia
Toxicon
12
Jan
2026
Botulinum Neurotoxin Potentiation by Excitation-Contraction Coupling Inhibitors
Toxicon
12
Jan
2026
Nonparalytic Botulinum-derived Molecules "El-Ibont" in Painful Diabetic Neuropathy
Toxicon
12
Jan
2026
Identifying Post-Stroke Spasticity in Swedish Healthcare Registers: A Real-World Analysis
Toxicon
12
Jan
2026
Paving the Way for a New Local Peripheral Neuropathic Pain Treatment: Proof-of-Concept Clinical Trial With IncobotulinumtoxinA (PaiNT)
Toxicon
12
Jan
2026
Induction of Apoptotic Cell Death by Lidocaine on Human iPSC-Derived GABA Neurons Used in a Cell-Based BoNT-A Potency Assay
Toxicon
12
Jan
2026
Efficacy of Dysport® in the Treatment of Tremulous Cervical Dystonia due to Vitamin E Deficiency: About 2 Families
Toxicon
12
Jan
2026
Beyond Motor Symptoms: Central Effects of Botulinum Neurotoxin on Anxiety and Depression in Focal Dystonia, Hemifacial Spasm, and Blepharospasm
Toxicon
12
Jan
2026
Identification and Characterization of Botulinum Neurotoxin-like Two-Component Toxins in Paeniclostridium ghonii
Toxicon
12
Jan
2026
Nonclinical Comparison of IncobotulinumtoxinA, Coretox, and LanbotulinumtoxinA
Toxicon
12
Jan
2026
Cervical Dystonia: Is it Time to Tweak and Twist the Diagnostic Criteria?
Toxicon
12
Jan
2026
Use of AbobotulinumtoxinA for Camptocormia Correction in Multiple Sclerosis: A Case Report
Toxicon
12
Jan
2026
Mechanisms of RTP004 Peptide Facilitation of BoNT-A Internalization and SNAP25 Cleavage
Toxicon
12
Jan
2026
Functional and Postural Effects of Botulinum Toxin on Proximal Muscles in Cerebral Palsy: A Clinical Experience
Toxicon
12
Jan
2026
Cervical Dystonia in the 4D Eye—Development of an AI-Based System for Three-Dimensional Quantitative Motion Analysis
Toxicon
12
Jan
2026
Botulinum Toxin Therapy as an Effective Component of Neurorehabilitation in Children With Cerebral Palsy: A Clinical Observation Study
Toxicon
12
Jan
2026
Social Determinants of Health in Spasticity Toxin Treatment
Toxicon
12
Jan
2026
Long-Term Efficacy and Safety of Repeated Botulinum Toxin-A Injections Performed With Ultrasound and EMG Guides in High-Level Performing Musicians: A
Toxicon
12
Jan
2026
Neurophysiological and Clinical Effects of Botulinum Neurotoxin in Essential Blepharospasm
Toxicon
12
Jan
2026
Enhancing Botulinum Toxin Delivery in Spasticity Care: A Time Motion and Workflow Analysis Using QI-Inspired Methods
Toxicon
12
Jan
2026
Botulinum Neurotoxin Type A Signaling in Pain Modulation Within Human Sensory Neurons
Toxicon
12
Jan
2026
Real-world Evidence of Longevity of BoNT-A in Cervical Dystonia (RELY-CD)—Long-term Dose-Effect Outcomes With Complex-Free vs Complex-Containing Botul
Toxicon
12
Jan
2026
Comparative Efficacy and Safety of Abobotulinumtoxin-A and Onabotulinumtoxin-A in the Treatment of Hemifacial Spasm: A Retrospective Analysis
Toxicon
12
Jan
2026
Botulinum Toxin for Complex Regional Pain Syndromes
Toxicon
12
Jan
2026
Why, When and How to Treat Dynamic Forehead Lines With Neurotoxin
Toxicon
12
Jan
2026
The Role of Deeper Layer Neck Muscles in the Treatment of Cervical Dystonia – A Case Report
Toxicon
12
Jan
2026
Use of Botulinum Neurotoxin and Phenol for the Treatment of Muscle Tone Disorders in Adult Patients Treated at a Rehabilitation Center
Toxicon
12
Jan
2026
The Role of Ultrasound Guidance in Botulinum Neurotoxin A Injections for Facial Nerve Neuropathy and Hemifacial Spasm: Improving Efficacy and Safety
Toxicon
12
Jan
2026
A Differential Diagnosis When Botulinum Toxin Fails to Produce the Expected Effect in Presumed Cervical Dystonia – A Case History
Toxicon
12
Jan
2026
Prevalence and Management of Sialorrhea in Motor Neurone Disease: Experience From a Specialist MND Rehabilitation Clinic
Toxicon
12
Jan
2026
Intradermal Microtoxin and Immunogenicity: Insights From Aesthetic, Therapeutic, and Vaccination Studies
Toxicon
12
Jan
2026
Correction of Severe Facial Asymmetry due to Congenital Muscle Shortening With Type A Botulinum Neurotoxin in a Child: A Case Report
Toxicon
12
Jan
2026
Botulinum Toxin A for Elbow Flexor Spasticity: Comparative Outcomes of Muscle-Specific Injection Strategies in Post-Stroke Patients
Toxicon
12
Jan
2026
Physician Assessment of Non-Medical Toxin Switching on Patient Care
Toxicon
12
Jan
2026
Cellular Responses to Botulinum Neurotoxin A Formulations: Implications With HSA and Polysorbates on Skin-Derived Cell Types
Toxicon
12
Jan
2026
Longitudinal Goal Attainment Across Four Consecutive Botulinum Neurotoxin Treatment Cycles in Adults With Upper Limb Spasticity
Toxicon
12
Jan
2026
Cloning, Expression, Purification and Characterization of the Twelve Subtypes of Botulinum Neurotoxin E1-E12
Toxicon
12
Jan
2026
Impact of Botulinum Toxin Type A on Care Facilitation: A Study Using Goal Attainment Scaling
Toxicon
12
Jan
2026
Integrated Immunogenicity Assessment of a Novel, First-in-Class TrenibotulinumtoxinE Across 5 Clinical Trials for Glabellar Lines
Toxicon
12
Jan
2026
Botulinum Toxin Injections for Drooling Improves Dysphagia in Patients With Parkinson Disease
Toxicon
12
Jan
2026
Developing Clinical Expertise in Spasticity Management: Experience From a 2-Day Interdisciplinary Course in Norway
Toxicon
12
Jan
2026
Bridging Disciplines Through Assessment of Comparative Botulinum Neurotoxin Research Across Etiologies: A Scoping and Narrative Review
Toxicon
12
Jan
2026
Botulinum Neurotoxin Type A Treatment for Sialorrhea and Cervical Dystonia in a Patient With Complex Dystonia due to a Novel Variant of the PDE10A Gen
Toxicon
12
Jan
2026
Botulinum Toxin Type A as a Pathogenetic Therapy for Musculoskeletal Pain in Degenerative Spinal Instability: A Case Series
Toxicon
12
Jan
2026
Rat Grip Strength Is a Sensitive and Reproducible Measure of OnabotulinumtoxinA-Induced Muscular Weakness
Toxicon
12
Jan
2026
Improvement in Upper Limb Spasticity Patterns in the Elderly Following Treatment With IncobotulinumtoxinA: A Pooled Analysis
Toxicon
12
Jan
2026
Botulinum Neurotoxin in First Bite Syndrome: A Case Report
Toxicon
12
Jan
2026
Moderate to Severe Upper Limb Spasticity Patterns in the Elderly Are Improved Following Treatment With IncobotulinumtoxinA: A Pooled Analysis
Toxicon
12
Jan
2026
Assessment of acute dermal toxicity of Croton pulegiodorus Baill. leaf essential oil in mice
Toxicon
12
Jan
2026
Is the Minipig a Feasible Large Animal Model for Intramuscular Botulinum Neurotoxin Type A Injection?
Toxicon
12
Jan
2026
A Stable and Effective Vaccine Platform for Multivalent Protection Against Botulinum Neurotoxins A, B, and E
Toxicon
12
Jan
2026
Innervation Induces a Distinct Force–Frequency Phenotype in 3D Human Neuromuscular Junction Tissues
Toxicon
12
Jan
2026
Factors Influencing the Outcome of Botulinum Neurotoxin Treatment in Botulinum Toxin-Naïve Patients With Cervical Dystonia
Toxicon
12
Jan
2026
Telehealth Follow-Up for Chronic Migraine Treated With OnabotulinumtoxinA: Patient-Reported Satisfaction
Toxicon
12
Jan
2026
Mentalis, DAO, and Platysma Muscles Treatment Using Botulinumtoxin A: A Multidisciplinary Italian Consensus Based on Literature Review
Toxicon
12
Jan
2026
Botulinum Toxin Type A for Refractory Neuropathic Pain After Cervicotomy and Thoracotomy: A Case Report
Toxicon
12
Jan
2026
Patient Perspectives on Nonmedical Toxin Switching and Care
Toxicon
12
Jan
2026
A Sensitive Cell Based Assay for Measuring Tetanus Toxin Activity
Toxicon
12
Jan
2026
Methodology of the BEOND Phase 3 Clinical Trials for Evaluating AbobotulinumtoxinA for Migraine Prevention
Toxicon
12
Jan
2026
Design of Novel Fusion Receptor Proteins to Enable Specific Binding of Botulinum Neurotoxins in a Native-like Membrane Environment
Toxicon
12
Jan
2026
Differential Response to Botulinum Neurotoxin in Stiff Knee Gait Subtypes of Runner’s Dystonia: A Gait-Based Stratification Approach
Toxicon
12
Jan
2026
Rapid Onset and Short Duration of TrenibotulinumtoxinE for Treatment of Moderate to Severe Glabellar Lines: Efficacy and Safety Results from a Phase 3
Toxicon
12
Jan
2026
Type A Toxin Protocol for Chronic Migraine Without Aesthetic Alteration. FaceLess Injection PAradigm Study (FLIPAS)
Toxicon
12
Jan
2026
Severe Case of Distant Spread of Botulinum Neurotoxin Type A (BoNT-A) After Cosmetic Treatment, Leading to Jaw Displacement
Toxicon
12
Jan
2026
Sensitivity and Specificity of the Poststroke Spasticity Monitoring Questionnaire (PSMQ) for Remote Monitoring of Spasticity Development: Interim Anal
Toxicon
12
Jan
2026
Botulinum Neurotoxin Therapy in the Treatment of Prolonged Hemifacial Spasm in Combination With Facial Neuropathy
Toxicon
12
Jan
2026
Effective Management of Hemiballismus With AbobotulinumA (BoNT-A) in a Patient With Brain Gunshot Injuries Contraindicating DBS Surgery
Toxicon
12
Jan
2026
Are All Microtoxins Equivalent?
Toxicon
12
Jan
2026
Type A Toxin Protocol for Chronic Migraine Without Aesthetic Alteration. FaceLess Injection PAradigm Study (FLIPAS)
Toxicon
12
Jan
2026
Comparing the Impact of the High-Concentration Capsaicin Topical System (HCCTS) on Pain and Sleep in Patients With Painful Diabetic Peripheral Neuropa
Toxicon
12
Jan
2026
Standardized Electromyography Methodology for the Identification and Classification of Dystonic Muscles—A Proposed New Scale
Toxicon
12
Jan
2026
Restoring a Healthier Nerve Phenotype: Mechanistic Insights into High-Concentration Capsaicin Topical System (HCCTS) for Painful Diabetic Peripheral N
Toxicon
12
Jan
2026
Botulinum Toxin A Treatment for Disabling Paratonia in Advanced Dementia: A Retrospective Chart Review
Toxicon
12
Jan
2026
Effectiveness of Botulinum Toxin Type A in Trigeminal Postherpetic Neuralgia: A Case Report
Toxicon
12
Jan
2026
Pathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Central Lesions
Toxicon
12
Jan
2026
Functional Condition of the Spinal Extensor Muscles in Postural Deformities in Patients With Parkinson's Disease
Toxicon
12
Jan
2026
Crystal Structure of the Catalytic Domain of BoNT-X in Complex With its Substrate, VAMP2
Toxicon
12
Jan
2026
Enhanced Duration of Effect in Crow’s Feet With Multi-Area Neurotoxin Injection: A Kaplan-Meier Analysis from ULTRA I and II
Toxicon
12
Jan
2026
Ukrainian National Consensus Statement on Botulinum Toxin Therapy for Neuropathic Pain: A Multidisciplinary Initiative in Times of War
Toxicon
12
Jan
2026
High Subject Satisfaction With AbobotulinumtoxinA Treatment of Glabellar Lines Post-Marketing Across the Globe
Toxicon
12
Jan
2026
OnabotulinumtoxinA Alters Pro- and Anti-Inflammatory Dural Macrophage Response to CSD in Female Mice
Toxicon
12
Jan
2026
Botulinum Toxin Treatment Outcomes in Dystonia: A Retrospective Analysis of Clinical and Treatment-Related Predictors
Toxicon
12
Jan
2026
Botulinum Toxin Type A for Residual Limb Pain After Combat Trauma: A 70-Patient Prospective Cohort
Toxicon
12
Jan
2026
Ultrasound-Guided BoNT-A Injection of the Subscapularis Muscle: A Practical Guide to the Dorsal Approach
Toxicon
12
Jan
2026
IncobotulinumtoxinA to Balance Eyebrows and Facial Shapes
Toxicon
12
Jan
2026
Botulinum Neurotoxin Type A Modulates Voltage-gated Ion Channels in Human Sensory Neurons
Toxicon
12
Jan
2026
BoNT Gene Therapy—Unleash the Beast or Overcome the Restraints?
Toxicon
12
Jan
2026
Unlocking Pain Relief: The Impact of Botulinum Neurotoxin on Muscle Function in Temporomandibular Disorders
Toxicon
12
Jan
2026
Botulinum Neurotoxin Prophylaxis for Sialorrhea in Dementia: A Case Report on Preventing Recurrent Bronchopneumonia and Improving Clinical Outcomes
Toxicon
12
Jan
2026
Assembly of Medium Progenitor Toxin Complexes and HA Complexes Into a Large Botulinum Neurotoxin Complex
Toxicon
12
Jan
2026
Phenomenological Approach To Spastic Movement Disorders
Toxicon
12
Jan
2026
Perineural IncobotulinumtoxinA Injections for Painful Diabetic Neuropathy: Preliminary Results From the PINBOT Phase II Trial
Toxicon
12
Jan
2026
Changes in Muscle Tone After Electrotherapy in Patients With Chronic Migraine and Cervicalgia
Toxicon
12
Jan
2026
Incidence of Dysphagia and Neck Weakness Following EMG-Guided Botulinum Neurotoxin Injections for Cervical Dystonia, With and Without EMG Neck Mapping
Toxicon
12
Jan
2026
Botulinum Toxin Type A in the Treatment of Synkinesis: Clinical Case Study
Toxicon
12
Jan
2026
Contribution of Botulinum Neurotoxin in Brace Adjustment and Pelvic Correction in Children With Cerebral Palsy
Toxicon
12
Jan
2026
Stability of Botulinum Neurotoxin Type A in the Presence of Lidocaine
Toxicon
12
Jan
2026
A Next-Generation Recombinant Botulinum Toxin With Enhanced Activity and Longer Duration of Action
Toxicon
12
Jan
2026
Evaluation of Botulinum Neurotoxin in the Modulation of Post-Burn Scars: Clinical Follow-up at 180 Days
Toxicon
12
Jan
2026
The Membrane Localization Domain (MLD) of Botulinum Neurotoxin A1 is Essential for Its Long Duration of Action
Toxicon
12
Jan
2026
IncobotulinumtoxinA Injections for Combined Management of Spasticity and Sialorrhea in Children With Cerebral Palsy: Results From a Retrospective Stud
Toxicon
12
Jan
2026
A Clinical Study of Incobotulinumtoxin-A for Calf Contouring: Effectiveness, Safety and Modifying Factors
Toxicon
12
Jan
2026
Identifying and Addressing the Barriers to Spasticity Management Across the Post-Stroke Continuum
Toxicon
12
Jan
2026
Influence of Sex on the Efficacy of Botulinum Toxin Type A in Chronic Neuropathic Pain
Toxicon
12
Jan
2026
Restoring Affection: Botulinum Neurotoxin for Facial Allodynia in a Severely Disabled Person
Toxicon
12
Jan
2026
"My Name Is Legion; for We Are Many”—Mechanisms That Generate Diversity in Botulinum Neurotoxin Serotypes and Subtypes From BoNT-producing Clostridia
Toxicon
12
Jan
2026
Secondary Treatment Failure With Botulinum Neurotoxin Type A: A Systematic Review and Meta-Analysis
Toxicon
12
Jan
2026
Subanalysis of the Therapeutic Goals with GAS Scale in Multiple Sclerosis Spasticity Treatment with Botulinum Toxin A (LINITOX Study)
Toxicon
12
Jan
2026
Real-World Use of Botulinum Neurotoxin Type A in Post-Stroke Spasticity Between 2015 and 2023: Insights From France
Toxicon
12
Jan
2026
Novel Hydrogel-Based Formulation for Botulinum Neurotoxin Controlled Release
Toxicon
12
Jan
2026
Application of Goal Attainment Scaling in Botulinum-Neurotoxin-Naive Patients With Cervical Dystonia—A Comparative Pilot Study
Toxicon
12
Jan
2026
How Experts Treat Spasticity Using Botulinum Neurotoxin (BoNT) in Germany
Toxicon
12
Jan
2026
Evaluating the Efficacy and Safety of Incobotulinumtoxin-A for Trapezius Muscle Reduction: Quantitative Evaluation With Imaging Studies
Toxicon
12
Jan
2026
Optimization of Botulinum Toxin Injections for Lower Camptocormia in Parkinson's Disease
Toxicon
12
Jan
2026
Quality of Life (QoL) Improvements in Patients With Leg Spasticity Following Treatment With AbobotulinumtoxinA: Assessment Using a Disease-Specific an
Toxicon
12
Jan
2026
Botulinum Neurotoxin as a Tool to Study Neuromuscular Junction Plasticity
Toxicon
12
Jan
2026
Reduction of Masseter Muscle Prominence After Treatment With OnabotulinumtoxinA: Results From a Phase 3 Double-Blind, Randomized, Placebo-Controlled S
Toxicon
12
Jan
2026
Clinical Effects of Botulinum Toxin Type A Combined With Extracorporeal Shockwave Therapy on Plantar Flexor Spasticity in Cerebral Palsy: A Pilot Stud
Toxicon
12
Jan
2026
Botulinum Toxin Dosing Trends in Long-Term Treatment for Hemifacial Spasm: A Retrospective Study
Toxicon
12
Jan
2026
Domains Analyzed in Studies on Cervical Dystonia
Toxicon
12
Jan
2026
Investigating the Mechanism of Action of OnabotulinumtoxinA in the Trigeminal Sensory System in preclinical orofacial pain
Toxicon
12
Jan
2026
RelaBoNT-A Treatment of Glabellar Lines and Lateral Canthal Lines of Different Baseline Severity: Subgroup Analyses of Pooled Phase III Study Data
Toxicon
12
Jan
2026
Therapeutic Approach With Botulinum Toxin in Autosomal Dominant Demyelinating Leukodystrophy: A Case Report
Toxicon
12
Jan
2026
The Effects of Botulinum Neurotoxin Type A on the Proximal Muscles of the Upper Limbs in a Patient With Severe Tremor due to Multiple Sclerosis: A Cas
Toxicon
12
Jan
2026
Interim Analysis of the Non-Interventional SMART Study on the Effectiveness and Safety of AbobotulinumtoxinA Injections in Everyday Practice in Patien
Toxicon
12
Jan
2026
Transcriptome based functional atlas of venomous spines: a first report on Dwarf lionfish
Toxicon
12
Jan
2026
AFM1 binding by Lactobacillus acidophilus, Lactobacillus rhamnosus and Enterococcus faecalis in human breast milk under different incubation condition
Toxicon
12
Jan
2026
Editorial Board
Toxicon
12
Jan
2026
Drug-Induced Sialorrhea
Toxicon
12
Jan
2026
Digitalized Treatment Diary for Managing Spasticity
Toxicon
12
Jan
2026
Botulinum Neurotoxin A Mutants With Enhanced Ganglioside Binding Show Improved Potency and Altered Ganglioside Selectivity
Toxicon
12
Jan
2026
IncobotulinumtoxinA (IncoBoNT-A) Reduced Evoked and Spontaneous Pain Related Behavior in a Neuropathic Pain Model in Rats
Toxicon
12
Jan
2026
Intralesional IncobotulinumtoxinA versus Corticosteroid for Plantar Fasciitis: Comparative Outcomes in Pain Reduction
Toxicon
12
Jan
2026
Can Focused Extracorporeal Shock Wave Therapy Prolong the Effect Of Botulinum Toxin Type A in Poststroke Spastic Equinus? A Randomized Controlled Tria
Toxicon
12
Jan
2026
Japanese Multicenter Study of Incobotulinum Toxin for Sialorrhea
Toxicon
12
Jan
2026
Primary Results of the Initial Validation of the SMD Decision Tree – I-REFER
Toxicon
12
Jan
2026
Enhancing Treatment Outcomes for Spastic Equinus Foot in Children With Cerebral Palsy: A Multimodal Approach Including Extracorporeal Shock Wave Thera
Toxicon
12
Jan
2026
Effect of Early Use of Botulinum Toxin A on Goal Attainment in Post-Stroke Spasticity
Toxicon
12
Jan
2026
Influence of Low-Dose Botulinum Neurotoxin Therapy on Balance and Gait Control in Children With Cerebral Palsy
Toxicon
12
Jan
2026
Targeting Brain Tumor-Associated Proteases With Neurotoxin Derivatives
Toxicon
12
Jan
2026
Characteristics of IncobotulinumtoxinA Treatment for Limb Spasticity in a Real-World Setting: Dosing and Muscles Injected
Toxicon
12
Jan
2026
Voice Handicap Index as a Practical Tool for Dose Selection and Outcome Prediction in Adductor Spasmodic Dysphonia
Toxicon
12
Jan
2026
High-Dose Botulinum Neurotoxin Type A as a Predictive Tool for Selective Dorsal Rhizotomy Outcomes in Pediatric Spastic Diplegia
Toxicon
12
Jan
2026
NEDD4 Promotes Cytoskeletal Dynamics Involved in Botulinum Toxin Induced Nerve Sprouting
Toxicon
12
Jan
2026
Botulinum Toxin Application for Abdominal Hernia Repair: A Report of Two Cases
Toxicon
12
Jan
2026
Botulinum Neurotoxin Injection: It’s a Skill, Not a Pill
Toxicon
12
Jan
2026
Systematic Review and Meta-Analysis of Neutralizing Antibodies to Botulinum Neurotoxin Type A in Multiple Indications
Toxicon
12
Jan
2026
Editorial Board
Toxicon
12
Jan
2026
Low-dose Intestinal Exposure to Botulinum Neurotoxins Increases Susceptibility to Salmonella and Shigella Infection
Toxicon
12
Jan
2026
The Effect of Botulinum Neurotoxin Injection on Non-Motor Symptoms of Cervical Dystonia: A Prospective Observational Study
Toxicon
12
Jan
2026
What to Consider When Developing a Service to Manage and Treat Sialorrhea in Chronic Neurological Conditions
Toxicon
12
Jan
2026
Cytotoxic Effects of Pharmaceutical Botulinum Neurotoxin Type A Formulation Components
Toxicon
12
Jan
2026
The Usefulness of Instrumented Gait Analysis in Monitoring the Quality of Gait Before and After Foot and Ankle Surgery for Spasticity
Toxicon
12
Jan
2026
A High-Throughput Human Neuromuscular Junction-on-a-Chip Platform to Advance Therapeutic Botulinum Neurotoxin Applications and Countermeasures Develop
Toxicon
12
Jan
2026
A Service Evaluation on the Use of IncobotulinumtoxinA for Treating Clozapine-Induced Sialorrhea
Toxicon
12
Jan
2026
Regional Differences in Use of Injection Guidance and Goal Attainment Following Repeat AbobotulinumtoxinA Injections: Subgroup Analysis of the AboLiSh
Toxicon
12
Jan
2026
The Impact of OnabotulinumtoxinA on Oral Pain Medication Use and Low-Value Care in Patients With Cervical Dystonia
Toxicon
12
Jan
2026
Clinical and Psychoemotional Characteristics of Patients With Cervical Dystonia and Dystonic Tremor: Their Influence on the Effectiveness of Botulinum
Toxicon
12
Jan
2026
Feasibility Study on the Use of an AI-Supported "Torticollis App" for Digital Movement and Posture Therapy in Isolated Cervical Dystonia
Toxicon
12
Jan
2026
Longitudinal Comparison of BoNT Dose Development Across Different Preparations in Patients With Cervical Dystonia
Toxicon
12
Jan
2026
Structure of the Complete 14-Subunit Botulinum Neurotoxin B Complex Reveals a Unique Anchoring Through the Narrow Central Pore of HA70
Toxicon
12
Jan
2026
30 Years of Developing Recombinant Human Antibodies to Botulinum Neurotoxins
Toxicon
12
Jan
2026
One-Year Follow-Up of Botulinum Toxin Injections in Masticatory Muscles for Temporomandibular Disorders: A Retrospective Descriptive Study
Toxicon
12
Jan
2026
Effect of Botulinum Neurotoxin Type A1 (BoNT-A1), Injected into the Detrusor, on Urodynamic Parameters in Conscious Rats
Toxicon
12
Jan
2026
Exploring Real-World Implications of Botulinum Neurotoxin A (BoNT-A) Immunoresistance for Consumer and Practitioners: Insights From the ASCEND Panel
Toxicon
12
Jan
2026
Use Of Botulinum Toxin in Patients With Dysphagia and Posterior Sialorrhea in Acute Ischemic Stroke
Toxicon
12
Jan
2026
Single-session AbobotulinumtoxinA for Analgesia in Children With Cerebral Palsy: A Prospective Cohort With 28-Week Follow-up
Toxicon
12
Jan
2026
Effects of Three Cycles of Progressively Higher Doses of Botulinum Toxin on Sagittal Kinematic Gait Parameters in People With Multifocal Spasticity Af
Toxicon
12
Jan
2026
IncobotulinumtoxinA for the Treatment of Glabellar and Forehead Dynamic Lines: A Brazilian Multicenter Real-Life Study
Toxicon
12
Jan
2026
Déjerine-Roussy Syndrome: Case Report
Toxicon
0.23122596740723